Alexis Ji

Alexis Ji currently works at NanoCellect Biomedical, Inc., as Director from 2017, Walking Fish Therapeutics, Inc., as Director, IIF Management Co. LLC, as Partner from 2016, Actym Therapeutics, Inc., as Board Member from 2020, and Primer Ventures LLC, as Founding Partner from 2023.
Dr. Ji also formerly worked at Merck & Co., Inc., as Senior Scientist from 2004 to 2009, ARCH Venture Partners LLC, as Venture Investment Consultant from 2012 to 2014, Roche Pharmaceuticals, Inc., as Senior Scientist from 2009 to 2010, Twist Bioscience Corp., as Board Observer from 2014 to 2018, SQZ Biotechnologies Co., as Board Observer from 2018 to 2020, Vivace Therapeutics, Inc., as Board Observer from 2015 to 2016, Life Technologies International BV, as Staff Scientist from 2010 to 2011, and WuXi Healthcare Ventures Management US LLC, as Principal from 2014 to 2016.
Dr. Ji received her doctorate degree from the University of Washington, undergraduate degree from Shandong University, and Masters Business Admin degree from The University of Chicago Booth School of Business.